In this study, we have identified that ligand-independent constitutive activation of EGFR maintains the proliferative ability of cancer cells in the absence of external ligands, and de novo fatty acid synthesis dependent palmitoylation of EGFR is required for both the ligand-independent constitutive activation and ligand-dependent activation of EGFR. The gene discussed is EGFR; the disease is cancer.